Cargando…
The role of Pygo2 for Wnt/ß-catenin signaling activity during intestinal tumor initiation and progression
Pygo2 acts as a co-activator of Wnt signaling in a nuclear complex with ß-catenin/BCL9/BCL9-2 to increase target gene transcription. Previous studies showed that Pygo2 is upregulated in murine intestinal tumors and human colon cancer, but is apparently dispensable for normal intestinal homeostasis....
Autores principales: | Talla, Suranand B., Brembeck, Felix H. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Impact Journals LLC
2016
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5348345/ https://www.ncbi.nlm.nih.gov/pubmed/27811361 http://dx.doi.org/10.18632/oncotarget.13016 |
Ejemplares similares
-
Pygo1 and Pygo2 roles in Wnt signaling in mammalian kidney development
por: Schwab, Kristopher R, et al.
Publicado: (2007) -
Epigenetics, Wnt signaling, and stem cells: the Pygo2 connection
por: Horsley, Valerie
Publicado: (2009) -
Chromatin effector Pygo2 regulates mammary tumor initiation and heterogeneity in MMTV-Wnt1 mice
por: Watanabe, Kazuhide, et al.
Publicado: (2013) -
SOX9 is an atypical intestinal tumor suppressor controlling the oncogenic Wnt/ß-catenin signaling
por: Prévostel, Corinne, et al.
Publicado: (2016) -
Mutations in Bcl9 and Pygo genes cause congenital heart defects by tissue-specific perturbation of Wnt/β-catenin signaling
por: Cantù, Claudio, et al.
Publicado: (2018)